SAB Biotherapeutics Inc Long-term Investment Intensity
SAB Biotherapeutics Inc long-term investment intensity. SAB Biotherapeutics Inc (SABS) has a Long-term Investment Intensity of 44.2% as of June 2026. Long-term investments of $105.35 Million represent 44.2% of total assets of $238.21 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read SAB Biotherapeutics Inc debt and liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of SAB Biotherapeutics Inc (2025–2025)
Long-term investment intensity of SAB Biotherapeutics Inc from 2025 to 2025. This chart shows how SAB Biotherapeutics Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of June 2026, the intensity stands at 44.2%, reflecting long-term investments of $105.35 Million against total assets of $238.21 Million USD.
SAB Biotherapeutics Inc Long-term Investment Intensity by Year (2025–2025)
SAB Biotherapeutics Inc long-term investment intensity by year from 2025 to 2025. The table below presents the year-by-year Long-term Investment Intensity for SAB Biotherapeutics Inc from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of SAB Biotherapeutics Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 27.1% | $46.89 Million | $172.81 Million | — |